3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
7248
Neoplasms
4547
Prostatic Neoplasms
3494
Colorectal Neoplasms
2941
Carcinoma, Non-Small-Cell Lung
2832
Lung Neoplasms
2548
Leukemia, Myeloid, Acute
1983
Pancreatic Neoplasms
1875
Multiple Myeloma
1812
Carcinoma, Hepatocellular
1735
Neoplasm Metastasis
1587
Stomach Neoplasms
1502
Lymphoma
1457
Head and Neck Neoplasms
1437
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1435
Brain Neoplasms
1374
Melanoma
1349
Ovarian Neoplasms
1347
Leukemia
1303
Rectal Neoplasms
1270
Recurrence
1255
Colonic Neoplasms
1204
Glioblastoma
1140
Uterine Cervical Neoplasms
1098
Lymphoma, Non-Hodgkin
1066
Leukemia, Lymphocytic, Chronic, B-Cell
989
Esophageal Neoplasms
965
Lymphoma, Follicular
938
Lymphoma, Large B-Cell, Diffuse
933
Squamous Cell Carcinoma of Head and Neck
921
Interventions
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Osteopetrosis, Autosomal Recessive 7
×
Clear all
NCT03691311
2021-11-03
D-BIOMARK
Institut Català d'Oncologia
Phase EARLY_PHASE1
Unknown
60 enrolled